Loading...
Market
How many new products will Element Biosciences launch by the end of 2024?
3
Resolution / Starting Odds
None • 25%
One • 25%
Two • 25%
Three or more • 25%
Company press releases, major tech and biotech news outlets
Story
Element Biosciences Raises $277 Million in Series D Venture Funding
Jul 12, 2024, 01:13 PM
Element Biosciences, a San Diego-based company specializing in next-generation sequencing (NGS), has successfully raised $277 million in a Series D venture funding round. The investment will enable the company to continue commercializing its AVITI benchtop genomic analyzer and launch its next product, AVITI24. This significant funding round positions Element Biosciences as a formidable competitor to Illumina in the DNA sequencing market. The company aims to leverage this capital to solidify its presence and drive rapid growth in the biotechnology sector.
View original story
Similar markets
0 • 25%
1 • 25%
2 • 25%
3 or more • 25%
None • 25%
1-2 institutions • 25%
3-5 institutions • 25%
More than 5 institutions • 25%
New AI course • 25%
AI teaching platform • 25%
AI tutoring service • 25%
Other • 25%
None • 25%
1 to 2 • 25%
3 to 4 • 25%
More than 4 • 25%
Messaging app for adults • 25%
Non-messaging app • 25%
AI-based tool • 25%
No new product • 25%
None • 25%
1-3 targets • 25%
4-6 targets • 25%
More than 6 targets • 25%
0 • 25%
1 • 25%
2-3 • 25%
4 or more • 25%
1 therapy • 25%
2 therapies • 25%
3 therapies • 25%
More than 3 therapies • 25%
None • 25%
One • 25%
Two • 25%
Three or more • 25%
1-2 projects • 25%
3-4 projects • 25%
5-6 projects • 25%
More than 6 projects • 25%
3 or more • 25%
2 • 25%
1 • 25%
None • 25%